Zhaoke Ophthalmology Signed an Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer
Shots:
- Zhaoke Ophthalmology to get an exclusive right to register, import, promote, distribute, market, and sell the Eye Lipid Mobilizer, a medical device for DED in Greater China (mainland China, Hong Kong, Macau, and Taiwan), South Korea & the ASEAN countries (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand & Vietnam)
- The clinical study showed compelling evidence of the efficacy of the device. A human factors research conducted in Mar 2022 revealed that ELM is intuitive and simple for patients to learn and operate
- ELM will be the first and only physician-prescribed home remedy for treating the root cause of dry eye disease, upon the US FDA clearance
Ref: PRNewswire | Image: Zhaoke
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
